Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT(TM) Glioblastoma Clinical Trial and Expands Trial Sites

Media coverage

• Title	Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT(TM) Glioblastoma Clinical Trial and Expands Trial Sites
  Media name/outlet	TD Ameritrade
  Country	United States
  Date	7/28/20
  Persons	Andrew Brenner

• Title	Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites
  Media name/outlet	Wallstreet Online
  Country	Germany
  Date	7/28/20
  Persons	Andrew Brenner

• Title	Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT Glioblastoma Clinical Trial and Expands Trial Sites
  Media name/outlet	India Pharma News
  Country	India
  Date	7/28/20
  Persons	Andrew Brenner

• Title	Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT„¢ Glioblastoma Clinical Trial and Expands Trial Sites
  Media name/outlet	PrimeNewswire (Top News)
  Country	United States
  Date	7/28/20
  Persons	Andrew Brenner